Mom Age 44 Cured Deadly Breast Cancer With CBD Oil, Refused

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
225
Mom Age 44 Cured Deadly Breast Cancer With CBD Oil, Refused Chemo

https://www.naturalblaze.com/2018/02/mom-age-...chemo.html

Dee Mani, Age 44, Cured Triple Negative Breast Cancer – the deadliest form – in 5 Months With CBD Oil After Refusing Chemo
Another UK patient is turning heads with another amazing testimony regarding their use of cannabis oil, or, CBD oil, which does not contain the psychoactive compounds that get you “high”.

Daily Mail reports:

A mother-of-two claims she has cured her aggressive breast cancer by taking one drop of cannabis oil every day.

Dee Mani, 44, refused chemotherapy when she was diagnosed with triple negative breast cancer – deemed the deadliest form – and instead opted to try CBD.

Doctors gave her the all-clear just five months after she opted for the oil, which is derived from cannabis but doesn’t cause a high.
Ms Mani, from Birmingham, found a lump in her breast in March 2017 and soon after was diagnosed with breast cancer.

Of course, her doctors offered her chemotherapy which is standard medical treatment. However, Dee refused because it failed to keep her sister alive. She decided to break out on her own and studied alternative medicine. That’s when she found out about cannabis oil and its accompanying claims.

In the UK, CBD oil is often sold as a supplement because the rules are a little murky, however, CBD oil is presumably allowed to be prescribed though it’s unlikely to be prevalent. In fact, the first Briton ever was only recently prescribed medical marijuana (different from CBD oil) to relieve deadly seizures.

She then found a local supplier which costing £22 ($34) a month and started taking the “revolting” cannabis oil once every evening. It bears noting that she also cleaned up her diet and began meditation. By August she was given the “all-clear” by her doctors.

She said:

Because of what happened to my sister, there was no way I was having chemo or radiotherapy.

At first when I spoke to the doctor I agreed to everything I was told, I said I’d have one year worth of chemotherapy but then I did my research.

After finding out about cannabis oil I started to put one drop into a capsule every night and take it before bed.

Within four months I believe that I cured myself and then when I was given the all clear, I knew it was the cannabis that cured me.

Alongside curing my cancer, it’s helped me with my insomnia, my allergy to dust and the pain in my back from having slipped discs.

Daily Mail cont.:

Cannabidiol, or CBD, is one of more than 80 cannabinoids, natural compounds found in the marijuana plant.

Extracted from the plant as a mineral-rich oil, it is usually bottled with a dropper – but also comes in the form of chewing gum, soap or as a vape oil for e-cigarettes.

It has no side effects, either, and is not addictive.

It has been reported to help people with epilepsy, rheumatism, migraines, psoriasis, acne, multiple sclerosis and depression.

Crucially, cannabidiol oil does not contain any THC, the psychoactive component of cannabis. In other words, CBD does not get you high.

Mani, who is still cancer-free, continues to take CBD oil each night. She has written about her journey in a new book called My Way.

Last year, a Scottish woman astonished the world when she cured her deadly brain tumor using CBD oil.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dahua Dives Deep into AIoT at IFA Berlin 2026

Updated Category News Views 1

Dahua's AIoT Vision Unfolds in Berlin Forget the coffee runs and the all-too-dry boardroom discussions—Dahua Technology has taken the stage at IFA Berlin 2026 and they're not just singing the same old tune. They're blasting through innovation barriers with a mix of AIoT—the next-gen tech cocktail everyone’s buzzing about. Leveraging AIoT might sound like...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 2

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 2

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
Labcorp Faces Lawsuit: Wiretapping Accusations Surface

Updated Category News Views 1

Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...

Continue Reading
XTEND Launches on NYSE Amid Market Milestones

Updated Category News Views 2

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Continue Reading
Graywind Redefines Flexibility with New Blinds 2.0

Updated Category News Views 2

Sliding blinds—who knew they'd stir up such a fuss? But here comes Graywind, rolling out their Manual Sliding Track Blinds 2.0, and it's clear they're turning heads in Santa Clara and beyond. This ain't your grandma's drapery setup. We're talking about a sleek, mid-to-premium panel-track system designed to cater to modern living spaces and architectural whimsy. It's...

Continue Reading
AEON's AI-Powered Agentic Checkout: A Game Changer?

Updated Category News Views 5

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

Continue Reading
GlocalMe Unveils Mobile Connectivity Innovations at IFA 2026

Updated Category News Views 3

Stepping into the Connectivity Future at IFA 2026 GlocalMe, a name synonymous with global mobile connections, made a splash at the IFA 2026 in Berlin. Equipped with a lineup built for the future, their presentation focused on lifestyle gadgets designed for constant online access. In a world where digital connection feels as vital as air, they've aligned perfectly with the...

Continue Reading
EF English Live's Approach to Workplace Confidence

Updated Category News Views 3

Pioneering English Confidence for the Global Workplace Stepping into a meeting with international partners requires more than just textbook knowledge of English. It's about confidently expressing ideas, adapting on the fly, and engaging with global colleagues. Enter EF English Live, a leader in transforming workplace communication through targeted English learning. Expert...

Continue Reading
Crocs Steps into Growth Frontier with Confident Strut

Updated Category News Views 2

Crocs' Dance with Destiny at 2026 Growth Frontiers Nothing like stepping into the spotlight, and Crocs, Inc. (NASDAQ: CROX) thinks it's doing just that at Piper Sandler's 2026 Growth Frontiers Conference. A livestream of their presentation is set for September 15, 11:30 AM ET. Now look, this ain’t just a parade of foam clogs and rubber, it’s about solidifying its...

Continue Reading

Top 5 Most Recently Viewed Articles

ZoomInfo Technologies Class Action: Know Your Rights Today

Updated Category News Views 83

Attention Investors: Class Action Lawsuit Filed Against ZoomInfo Technologies For investors in ZoomInfo Technologies, Inc. (NASDAQ: ZI), there’s important news: a major class action lawsuit has been initiated against the company and certain executives. This lawsuit stems from significant financial losses experienced by some investors, marking an essential opportunity...

Continue Reading
Innovative Windshield Wiper Guards Provide Winter Protection

Updated Category News Views 26

Introduction to Windshield Wiper Protectors Winter weather can be harsh on vehicles, especially windshield wipers that endure snow and ice accumulation. An innovative inventor recognized this issue and developed a solution: protective guards for windshield wipers, aptly named WINDSHIELD WIPER PROTECTORS. The goal is simple yet crucial: to keep wipers clean and dry,...

Continue Reading
Farmers and Merchants Bancshares Reports Strong Financial Results

Updated Category News Views 116

Financial Performance Overview Farmers and Merchants Bancshares, Inc. recently announced that its net income for the six months ending in June was $2.4 million, equating to $0.74 per share. This shows a solid performance compared to $2.3 million from the same timeframe the previous year. Importantly, the Company has maintained its return on average equity at 8.18%,...

Continue Reading
Amazon's Stock Performance and Future Growth Potential

Updated Category News Views 215

Amazon's Stock Performance in 2024 Amazon (NASDAQ: AMZN) has been a major force in the market, consistently delivering strong returns for its investors. However, 2024 has posed some challenges, as Amazon's stock has not kept pace with overall market performance. While Amazon's shares have increased by about 17.5% this year, the S&P 500 index has reported a total return of...

Continue Reading
Baird Upgrades Quest Diagnostics Stock Amid Positive Trends

Updated Category News Views 98

Baird Upgrades Quest Diagnostics Stock Amid Positive Trends On a recent Wednesday, Baird, a prominent financial services firm, announced it has upgraded its rating for Quest Diagnostics (NYSE: DGX) stock from Neutral to Outperform. Along with this upgrade, they increased the price target from $157 to an impressive $182. This positive adjustment stems from a bright outlook...

Continue Reading